Pfizer Return On Assets from 2010 to 2026
| PFE Stock | EUR 23.37 0.05 0.21% |
Return On Assets | First Reported 2010-12-31 | Previous Quarter 0.0432 | Current Value 0.0411 | Quarterly Volatility 0.04106933 |
Check Pfizer financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pfizer's main balance sheet or income statement drivers, such as Discontinued Operations of 6.6 M, Interest Expense of 3.7 B or Selling General Administrative of 11.2 B, as well as many indicators such as Price To Sales Ratio of 2.16, Dividend Yield of 0.0727 or PTB Ratio of 1.85. Pfizer financial statements analysis is a perfect complement when working with Pfizer Valuation or Volatility modules.
Pfizer | Return On Assets |
The Return On Assets trend for Pfizer Inc offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Pfizer is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Pfizer's Return On Assets Growth Pattern
Below is the plot of the Return On Assets of Pfizer Inc over the last few years. It is a profitability ratio that indicates the percentage of profit a company earns in relation to its overall resources. It is calculated by dividing net income by total assets. Pfizer's Return On Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pfizer's overall financial position and show how it may be relating to other accounts over time.
| Return On Assets | 10 Years Trend |
|
Return On Assets |
| Timeline |
Pfizer Return On Assets Regression Statistics
| Arithmetic Mean | 0.07 | |
| Geometric Mean | 0.06 | |
| Coefficient Of Variation | 58.34 | |
| Mean Deviation | 0.03 | |
| Median | 0.05 | |
| Standard Deviation | 0.04 | |
| Sample Variance | 0 | |
| Range | 0.1496 | |
| R-Value | (0.13) | |
| Mean Square Error | 0 | |
| R-Squared | 0.02 | |
| Significance | 0.61 | |
| Slope | (0) | |
| Total Sum of Squares | 0.03 |
Pfizer Return On Assets History
About Pfizer Financial Statements
Pfizer stakeholders use historical fundamental indicators, such as Pfizer's Return On Assets, to determine how well the company is positioned to perform in the future. Although Pfizer investors may analyze each financial statement separately, they are all interrelated. For example, changes in Pfizer's assets and liabilities are reflected in the revenues and expenses on Pfizer's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Pfizer Inc. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Assets | 0.04 | 0.04 |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of Pfizer Correlation against competitors. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.